A new dimension in drug discovery: reversing epithelial–mesenchymal transition (EMT)
Main Authors: | Yun-Ju Huang, Ruby, Yo-Yan Huang, Thomas |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133983/ |
Similar Items
-
Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)
by: Huang, Ruby Yun-Ju, et al.
Published: (2015) -
The Epithelial-to-Mesenchymal Transition (EMT), a Particular Case
by: Cebrià-Costa, Joan Pau, et al.
Published: (2014) -
The Phytochemical Shikonin Stimulates Epithelial-Mesenchymal Transition (EMT) in Skin Wound Healing
by: Yin, Shu-Yi, et al.
Published: (2013) -
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
by: Yoshida, T, et al.
Published: (2014) -
Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases
by: Zvaifler, Nathan J
Published: (2006)